Morgan Stanley Downgrades Accenture to Equal-Weight, Lowers Price Target to $177

Morgan Stanley analyst James Faucette downgrades Accenture (NYSE:ACN) from Overweight to Equal-Weight and lowers the price target from $240 to $177.